These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15486872)

  • 1. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Young EW; Akiba T; Albert JM; McCarthy JT; Kerr PG; Mendelssohn DC; Jadoul M
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):34-8. PubMed ID: 15486872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.
    Young EW; Albert JM; Satayathum S; Goodkin DA; Pisoni RL; Akiba T; Akizawa T; Kurokawa K; Bommer J; Piera L; Port FK
    Kidney Int; 2005 Mar; 67(3):1179-87. PubMed ID: 15698460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Kimata N; Akiba T; Pisoni RL; Albert JM; Satayathum S; Cruz JM; Akizawa T; Andreucci VE; Young EW; Port FK
    Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.
    Kimata N; Albert JM; Akiba T; Yamazaki S; Kawaguchi T; Fukuhara S; Akizawa T; Saito A; Asano Y; Kurokawa K; Pisoni RL; Port FK
    Hemodial Int; 2007 Jul; 11(3):340-8. PubMed ID: 17576300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Blayney MJ; Tentori F
    J Ren Care; 2009 Mar; 35 Suppl 1():7-13. PubMed ID: 19222725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
    Yokoyama K; Kurita N; Fukuma S; Akizawa T; Fukagawa M; Onishi Y; Kurokawa K; Fukuhara S
    Nephrol Dial Transplant; 2017 Mar; 32(3):534-541. PubMed ID: 26945054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients.
    Paniagua R; Ventura MD; Ávila-Díaz M; Hinojosa-Heredia H; Méndez-Duran A; Cisneros A; Gómez AM; Cueto-Manzano A; Trinidad P; Obrador GT; García-López E; Lindholm B
    Arch Med Res; 2013 Apr; 44(3):229-34. PubMed ID: 23398790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
    Lebner AC; Beard KM; Soroka SD; Cournoyer SH; Da Roza GA; Geary DF; Mendelssohn DC
    Nephrol Dial Transplant; 2011 Jan; 26(1):156-63. PubMed ID: 20667990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Yamamoto S; Karaboyas A; Komaba H; Taniguchi M; Nomura T; Bieber BA; De Sequera P; Christensson A; Pisoni RL; Robinson BM; Fukagawa M
    BMC Nephrol; 2018 Oct; 19(1):253. PubMed ID: 30290781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices.
    Combe C; McCullough KP; Asano Y; Ginsberg N; Maroni BJ; Pifer TB
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):39-46. PubMed ID: 15486873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Pisoni RL; Zepel L; Fluck R; Lok CE; Kawanishi H; Süleymanlar G; Wasse H; Tentori F; Zee J; Li Y; Schaubel D; Burke S; Robinson B
    Am J Kidney Dis; 2018 Apr; 71(4):469-478. PubMed ID: 29198387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Al Salmi I; Larkina M; Wang M; Subramanian L; Morgenstern H; Jacobson SH; Hakim R; Tentori F; Saran R; Akiba T; Tomilina NA; Port FK; Robinson BM; Pisoni RL
    Am J Kidney Dis; 2018 Nov; 72(5):634-643. PubMed ID: 30146421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.
    Pisoni RL; Gillespie BW; Dickinson DM; Chen K; Kutner MH; Wolfe RA
    Am J Kidney Dis; 2004 Nov; 44(5 Suppl 2):7-15. PubMed ID: 15486868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 20. [The Dialysis Outcomes and Practice Patterns Study (DOPPS): results of the Italian cohort].
    Pontoriero G; Santoro D; Messina A; Vitiello P; Tasco A; Milei M; Capiferri R; Bellazzi R; Flammini A; Baroni A; Morra M; Cappelli G; Mucaria S; Boggi R; Amico ME; Volzone A; D'andrea T; Paglionico C; Antonucci F; Ivaldi R; Tentori F; Bragg-Gresham J; Pisoni R; Andreucci VE; Locatelli F
    G Ital Nefrol; 2005; 22(5):494-502. PubMed ID: 16267807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.